Shilpa Medicare Ltd - 530549 - Announcement U/R 30 OF SEBI(LODR) Regulations, 2015
Shilpa Medicare Limited enters Phase I Clinical Trial for its New Biological Entity, recombinant Human Albumin01-11-2021
01-11-2021
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Investor Presentation
presentation made to analysts / institutional investors.29-10-2021
SHILPA MEDICARE LTD. - 530549 - UN AUDITED FINANCIAL RESULTS FOR QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER, 2021
Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the Second Quarter and half year ended 30 September 202129-10-2021
SHILPA MEDICARE LTD. - 530549 - Board Meeting Outcome for UN AUDITED FINANCIAL RESULTS AS ON 30TH SEPTEMBER, 2021
Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the Second Quarter AND Half Year ended 30 September 2021.29-10-2021
SHILPA MEDICARE LTD. - 530549 - Clarification On Board Meeting
This is to clarify that the Board Meeting of Shilpa Medicare Limited to discuss and approve the 'Unaudited Standalone and Consolidated Financial Results of the Company' for the Second Quarter ended 30th September, 2021 will be held on Friday, 29th October, 2021. Kindly take the same on record.24-10-2021
Shilpa Medicare Ltd - 530549 - Clarification On Board Meeting
This is to clarify that the Board Meeting of Shilpa Medicare Limited to discuss and approve the 'Unaudited Standalone and Consolidated Financial Results of the Company' for the Second Quarter ended 30th September, 2021 will be held on Friday, 29th October, 2021. Kindly take the same on record.24-10-2021
Shilpa Medicare Ltd - 530549 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2021 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors of Shilpa Medicare Limited will be held on Friday, the 29th Day of August, 2021, to inter alia transact the following items of business: Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Second Quarter ended 30th September, 2021. This is for your information and records23-10-2021
SHILPA MEDICARE LTD. - 530549 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- V V KRISHNA CHAITANYADesignation :- Company Secretary and Compliance Officer20-10-2021
SHILPA MEDICARE LTD. - 530549 - Notice Of The Extra Ordinary General Meeting Of The Company
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, We are attaching herewith the Notice convening Extraordinary General Meeting ('EGM') of the Company scheduled on Wednesday, 10 November 2021 at 2:00 PM ('IST') through Video Conferencing ('VC')/ Other Audio- Visual Means ('OAVM') to transact the business as set forth in the notice of the meeting.19-10-2021
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In continuation to the outcome of the Board meeting provided today i.e., 14 October 2021 with regard to issue of 52.75 lacs equity shares on preferential basis to various marquee investors aggregating to Rs. 297.51 crores at a price of Rs. 564 per share, please find enclosed copy of Media Release.14-10-2021